Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

May 15, 2017

Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
TUCSON, Ariz., May 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock today, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $2...Read more

May 9, 2017

Accelerate Diagnostics Announces Pricing of Upsized Public Offering of Common Stock
TUCSON, Ariz., May 09, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 2,750,000 shares of its common stock, upsized from the original share offering of 2,500,000 shares of common stock, at a price to the public of $28.85 per share. All of the shares are being s...Read more

May 8, 2017

Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
TUCSON, Ariz., May 08, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced that it has commenced an underwritten public offering of 2,500,000 shares of its common stock. All of the shares are being offered by Accelerate Diagnostics. In addition, Accelerate Diagnostics expects to grant the underwriters of the offeri...Read more

May 3, 2017

Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017
TUCSON, Ariz., May 03, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation contracts covering 169 instruments, 22 additional instruments converted into revenue generating placements, and revenue growth exceeding 325% of the sam...Read more

Apr 18, 2017

Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd
TUCSON, Ariz., April 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 3rd, 2017 to discuss its first quarter 2017 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, ...Read more

Mar 15, 2017

Accelerate Diagnostics Names Tom Brown to Board of Directors
TUCSON, Ariz., March 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Tom Brown to the company's board of directors. His appointment is effective March 14, 2017. Brown's appointment adds over 30 years of medical diagnostics expertise to the company's board of directors. Beginning his career with the A...Read more

Feb 23, 2017

Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly fro...Read more

Feb 23, 2017

Accelerate Diagnostics to Report Preliminary Fourth Quarter and Full Year 2016 Results on February 27th
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced it will report preliminary fourth-quarter and full year 2016 financial results on Monday, February 27th, 2017. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will host a conference call to...Read more

Dec 14, 2016

Accelerate Diagnostics to Present at the 35th Annual J.P. Morgan Healthcare Conference
TUCSON, Ariz., Dec. 14, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that it will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2017 at 11:00 a.m. PT. A live audio webcast of the presentation will be accessible from the investor portal of the company's w...Read more

Nov 22, 2016

Accelerate Diagnostics to Present at the Piper Jaffray 28th Annual Healthcare Conference on November 30th
TUCSON, Ariz., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer, is scheduled to present at the Piper Jaffray 28th Annual Healthcare Conference in New York City, NY on Wednesday, November 30th at 2:00 PM EST. A live audio webcast of the presentation wil...Read more
FirstPrevious
1
2
3
4
...
8
Next Last

= add release to Briefcase
NASDAQ: AXDX
$ 26.30
+0.25
(0.96%)
4:00 PM ET on Nov 22, 2017
Day High: 26.60
Day Low:  25.90
Volume:    765,709
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates